Gwangju, South Korea

Yong-Doo Choi

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong-Doo Choi. Retrieved from https://idiyas.com/inventor/yong-doo-choi-16h4veaj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 38(Granted Patents)


Company Filing History:

goldMedal1 out of 834,659 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yong-Doo Choi: Innovator in Controlled Drug Release Systems

Introduction

Yong-Doo Choi is a notable inventor based in Kwangju, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative approaches to controlled drug release.

Latest Patents

One of his key patents is titled "Controlled drug release system of retinoic acid." This invention focuses on a controlled drug release system that incorporates a specific ratio of retinoic acid into a microsphere. The microsphere is composed of biodegradable polymer and amphoteric block copolymer, which contains both hydrophilic and hydrophobic groups. This advancement has the potential to enhance the efficacy of drug delivery in medical applications.

Career Highlights

Yong-Doo Choi has been recognized for his innovative work in the pharmaceutical field. His research and development efforts have led to advancements that could improve patient outcomes through more effective drug delivery mechanisms. He holds 1 patent that showcases his expertise and commitment to innovation.

Collaborations

Yong-Doo Choi has collaborated with several professionals in his field, including Young-Ro Byun and Sang-Yoon Kim. These collaborations have likely contributed to the development and refinement of his innovative ideas.

Conclusion

Yong-Doo Choi is a prominent inventor whose work in controlled drug release systems demonstrates his dedication to advancing medical technology. His contributions are paving the way for more effective treatments in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…